Strandberg L - Search Results

1

The oxidative inactivation of plasminogen activator inhibitor type 1 results from a conformational change in the molecule and does not require the involvement of the P1' methionine.

Strandberg L, Lawrence DA, Johansson LB, Ny T. Strandberg L, et al. J Biol Chem. 1991 Jul 25;266(21):13852-8. J Biol Chem. 1991. PMID: 1856219 Free article.

2

A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate.

Urano T, Strandberg L, Johansson LB, Ny T. Urano T, et al. Among authors: strandberg l. Eur J Biochem. 1992 Nov 1;209(3):985-92. doi: 10.1111/j.1432-1033.1992.tb17372.x. Eur J Biochem. 1992. PMID: 1425706 Free article.

3

Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants.

Lawrence DA, Strandberg L, Ericson J, Ny T. Lawrence DA, et al. Among authors: strandberg l. J Biol Chem. 1990 Nov 25;265(33):20293-301. J Biol Chem. 1990. PMID: 1700786 Free article.

4

Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.

Lawrence D, Strandberg L, Grundström T, Ny T. Lawrence D, et al. Among authors: strandberg l. Eur J Biochem. 1989 Dec 22;186(3):523-33. doi: 10.1111/j.1432-1033.1989.tb15238.x. Eur J Biochem. 1989. PMID: 2514093 Free article.

5

The organization of the human-plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family.

Strandberg L, Lawrence D, Ny T. Strandberg L, et al. Eur J Biochem. 1988 Oct 1;176(3):609-16. doi: 10.1111/j.1432-1033.1988.tb14320.x. Eur J Biochem. 1988. PMID: 3262512 Free article.

6

Time-resolved polarized fluorescence spectroscopy studies of plasminogen activator inhibitor type 1: conformational changes of the reactive center upon interactions with target proteases, vitronectin and heparin.

Fa M, Karolin J, Aleshkov S, Strandberg L, Johansson LB, Ny T. Fa M, et al. Among authors: strandberg l. Biochemistry. 1995 Oct 24;34(42):13833-40. doi: 10.1021/bi00042a015. Biochemistry. 1995. PMID: 7577977

7

Biochemical and biophysical studies of reactive center cleaved plasminogen activator inhibitor type 1. The distance between P3 and P1' determined by donor-donor fluorescence energy transfer.

Aleshkov SB, Fa M, Karolin J, Strandberg L, Johansson LB, Wilczynska M, Ny T. Aleshkov SB, et al. Among authors: strandberg l. J Biol Chem. 1996 Aug 30;271(35):21231-8. doi: 10.1074/jbc.271.35.21231. J Biol Chem. 1996. PMID: 8702896 Free article.

8

Fluorescence studies on plasminogen activator inhibitor 1: reactive centre cysteine mutants remain active after fluorophore attachment.

Strandberg L, Karolin J, Johansson LB, Fa M, Aleshkov S, Ny T. Strandberg L, et al. Thromb Res. 1994 Nov 1;76(3):253-67. doi: 10.1016/0049-3848(94)90197-x. Thromb Res. 1994. PMID: 7863476

9

Variants of tissue-type plasminogen activator with substantially enhanced response and selectivity toward fibrin co-factors.

Strandberg L, Madison EL. Strandberg L, et al. J Biol Chem. 1995 Oct 6;270(40):23444-9. doi: 10.1074/jbc.270.40.23444. J Biol Chem. 1995. PMID: 7559505 Free article.

10

Distinct contributions of residue 192 to the specificity of coagulation and fibrinolytic serine proteases.

Zhang YL, Hervio L, Strandberg L, Madison EL. Zhang YL, et al. Among authors: strandberg l. J Biol Chem. 1999 Mar 12;274(11):7153-6. doi: 10.1074/jbc.274.11.7153. J Biol Chem. 1999. PMID: 10066774 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters